BioCorRx Gross Margin Growth & History (BICX)

BioCorRx's gross margin was 77.60% for fiscal 2013.

BioCorRx annual gross margin history

BioCorRx annual gross margin

2010

2011

2012

2013

Fiscal year	Period ended	Gross margin	Change (percentage points)
2013	2013-12-31	77.60%	+23.96 pp
2012	2012-12-31	53.64%	+5.52 pp
2011	2011-12-31	48.12%	+56.30 pp
2010	2010-12-31	−8.18%	—

BioCorRx quarterly gross margin

Q1.11

Q2.11

Q3.11

Q4.11

Q1.12

Q2.12

Q3.12

Q4.12

Q1.13

Q2.13

Q3.13

Q1.14

Q2.14

Q3.14

Fiscal quarter	Period ended	Gross margin	Change (percentage points)
Q3 2014	2014-09-30	80.56%	−5.39 pp
Q2 2014	2014-06-30	80.14%	+0.57 pp
Q1 2014	2014-03-31	78.83%	−11.53 pp
Q3 2013	2013-09-30	100.00%	+131.08 pp
Q2 2013	2013-06-30	85.95%	+55.23 pp
Q1 2013	2013-03-31	79.57%	+40.65 pp
Q4 2012	2012-12-31	90.35%	+83.37 pp
Q3 2012	2012-09-30	−31.08%	−88.45 pp
Q2 2012	2012-06-30	30.71%	−27.13 pp
Q1 2012	2012-03-31	38.92%	+71.21 pp
Q4 2011	2011-12-31	6.98%	—
Q3 2011	2011-09-30	57.37%	—
Q2 2011	2011-06-30	57.84%	—
Q1 2011	2011-03-31	−32.29%	—

BioCorRx gross margin trends

Across the available reported history, BioCorRx's gross margin increased from 53.64% to 77.60%, a change of +23.96 percentage points. The latest reported quarter, Q3 2014, shows 80.56%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BioCorRx filings at SEC.gov ↗